Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000036558 | SCV000169021 | benign | not specified | 2014-06-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000621214 | SCV000736106 | likely benign | Cardiovascular phenotype | 2023-12-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000777959 | SCV000914060 | likely benign | Cardiomyopathy | 2018-10-08 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000777959 | SCV001333860 | uncertain significance | Cardiomyopathy | 2023-06-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001407760 | SCV001609739 | likely benign | Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 | 2023-08-31 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000777959 | SCV004821982 | likely benign | Cardiomyopathy | 2023-12-18 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000036558 | SCV000060213 | likely benign | not specified | 2008-05-14 | no assertion criteria provided | clinical testing |